Progress, challenges, and future of nanomedicine
Nanotherapeutics exhibit unique advantages in clinical outcomes compared with
conventional small molecular drugs. The past three decades have seen intensive research …
conventional small molecular drugs. The past three decades have seen intensive research …
Cancer nanomedicine: a review of recent success in drug delivery
Cancer continues to be one of the most difficult global healthcare problems. Although there
is a large library of drugs that can be used in cancer treatment, the problem is selectively …
is a large library of drugs that can be used in cancer treatment, the problem is selectively …
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer
JH Strickler, H Satake, TJ George… - New England journal …, 2023 - Mass Medical Soc
Abstract Background KRAS p. G12C mutation occurs in approximately 1 to 2% of pancreatic
cancers. The safety and efficacy of sotorasib, a KRAS G12C inhibitor, in previously treated …
cancers. The safety and efficacy of sotorasib, a KRAS G12C inhibitor, in previously treated …
Antiemetics: American Society of Clinical Oncology clinical practice guideline update
PJ Hesketh, MG Kris, E Basch, K Bohlke… - Journal of Clinical …, 2017 - ascopubs.org
Purpose To update the ASCO guideline for antiemetics in oncology. Methods ASCO
convened an Expert Panel and conducted a systematic review of the medical literature for …
convened an Expert Panel and conducted a systematic review of the medical literature for …
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global …
Background Nanoliposomal irinotecan showed activity in a phase 2 study in patients with
metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based …
metastatic pancreatic ductal adenocarcinoma previously treated with gemcitabine-based …
Cancer nanotechnology: a new revolution for cancer diagnosis and therapy
VK Chaturvedi, A Singh, VK Singh… - Current drug …, 2019 - ingentaconnect.com
Background: Nanotechnology is gaining significant attention worldwide for cancer treatment.
Nanobiotechnology encourages the combination of diagnostics with therapeutics, which is a …
Nanobiotechnology encourages the combination of diagnostics with therapeutics, which is a …
New developments in liposomal drug delivery
BS Pattni, VV Chupin, VP Torchilin - Chemical reviews, 2015 - ACS Publications
New Developments in Liposomal Drug Delivery | Chemical Reviews ACS ACS Publications
C&EN CAS Find my institution Log In Chemical Reviews ACS Publications. Most Trusted. Most …
C&EN CAS Find my institution Log In Chemical Reviews ACS Publications. Most Trusted. Most …
Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications
A Wicki, D Witzigmann, V Balasubramanian… - Journal of controlled …, 2015 - Elsevier
Cancer is a leading cause of death worldwide. Currently available therapies are inadequate
and spur demand for improved technologies. Rapid growth in nanotechnology towards the …
and spur demand for improved technologies. Rapid growth in nanotechnology towards the …
Dendrimers: A versatile nanocarrier for drug delivery and targeting
Dendrimers are novel polymeric nanoarchitectures characterized by hyper-branched 3D-
structure having multiple functional groups on the surface that increases their functionality …
structure having multiple functional groups on the surface that increases their functionality …
An update on treatment options for pancreatic adenocarcinoma
Pancreatic cancer is one of the most lethal solid organ tumors. Due to the rising incidence,
late diagnosis, and limited treatment options, it is expected to be the second leading cause …
late diagnosis, and limited treatment options, it is expected to be the second leading cause …